Celltrion corona treatment clinical phase 2 results released on the 13th
The results of the Phase 2 clinical trial of Celltrion’s Corona 19 antibody treatment’Rekironaju’ will be released for the first time on the 13th.
According to the pharmaceutical and bio industry, Celltrion plans to announce the results of global phase 2 clinical trials of Rekirona by participating in a new drug development symposium hosted by the Korean Pharmacy Society on the 13th.
Earlier, Celltrion decided to announce it as early as possible, as concerns spread that the clinical results were engrossing without disclosing detailed clinical data at the request of the Ministry of Food and Drug Safety.
Celltrion plans to release the results of phase 2 clinical trials of Rekirona at an international conference soon.
Yonhap News TV article inquiries and reports: katok/line jebo23
(End)
–
